| Literature DB >> 20205741 |
Till Uhlig1, Camilla Fongen, Eldri Steen, Anne Christie, Sigrid Ødegård.
Abstract
BACKGROUND: Rheumatoid arthritis (RA) is a chronic, inflammatory and systemic disease which affects the musculoskeletal system. Exercise programmes are reported to improve physical functioning in patients with RA. Tai Chi is a traditional Chinese martial art which combines slow and gentle movements with mental focus. The purpose of this study was to study in which way Tai Chi group exercise impacted on disease activity, physical function, health status and experience in RA patients, applying quantitative and qualitative methods.Entities:
Mesh:
Year: 2010 PMID: 20205741 PMCID: PMC2845097 DOI: 10.1186/1471-2474-11-43
Source DB: PubMed Journal: BMC Musculoskelet Disord ISSN: 1471-2474 Impact factor: 2.362
Interview guide used in the focus group
| How was it for you to participate in Tai Chi? | |
| Do you in any way experience that Tai Chi | |
| had influence on your health? | |
| had influence on your daily life? | |
| lead to anything negative? | |
| How did you experience the group with respect to | |
| relations to other group members and to group leaders? | |
| structure (group size, duration of sessions)? | |
| If you were to recommend Tai Chi to others, what would you say? | |
| Would you like to add something? |
Baseline characteristics of Tai Chi participants and focus group subsample
| Tai Chi group (n = 13) | Focus group subsample (n = 9) | |
|---|---|---|
| Gender female/male | 11/2 | 8/1 |
| Age (years) | 57 (33-70) | 57 (40-70) |
| Disease duration (years) | 6 (1-45) | 6 (1-45) |
| Co-morbidities (≥ 1) | 6 | 4 |
| Education | ||
| ≥ 12 years | 10 | 8 |
| < 12 years | 3 | 1 |
| Employment, full or part time | 8 | 6 |
| Disabled/retirement pension | 5 | 3 |
Values are median (range) or number.
Disease activity and physical performance tests measured at baseline (T0), end of intervention (T1), and 12 weeks follow-up (T2) (n = 13)
| T0 | T1 | p-value (T0-T1) | T2 | p-value (T0-T2) | |
|---|---|---|---|---|---|
| DAS28 | 4.7 (2.2-6.7) | 4.1 (1.1 - 6.0) | 0.04 | 4.7 (0.8-6.5) | 0.24 |
| No. swollen joints (0-28) | 11 (2 - 20) | 7 (0 - 17) | 0.01 | 5 (0 - 14) | 0.02 |
| No. tender joints (0-28) | 8 (1 - 29) | 4 (0 - 22) | 0.22 | 9 (0 - 20) | 0.40 |
| Patient global assessment (0-100) | 31 (1 - 51) | 21 (1 - 45) | 0.67 | 43 (6 - 61) | 0.39 |
| Doctor global assessment (0-100) | 32 (19 - 72) | 26 (3 -57) | 0.08 | 34 (0 - 55) | 0.42 |
| Figure-of-Eight balance | 2.5 (0 - 12) | 4 (0-11) | 0.24 | 2.5 (0 - 10) | 0.88 |
| Timed-Stands Test (sec) | 23 (13 - 34) | 15 (10 - 26) | 0.01 | 16 (10 - 28) | < 0.01 |
| Shoulder Movement Impact Scale (0-60) | 59 (46 - 60) | 59 (46 - 60) | 0.10 | 59 (41 - 60) | 0.08 |
| Pain during SMIS (0-100) | 8 (0 - 34) | 4 (0 - 22) | 0.06 | 10 (0 -19) | 0.70 |
Values are median (range)
DAS28 = Disease activity score
Health status measured at baseline (T0), end of intervention (T1), and 12 weeks follow-up (T2) (n = 13)
| T0 | T1 | p-value (T0-T1) | T2 | p-value (T0-T2) | |
|---|---|---|---|---|---|
| HAQ (0-3) | 0.5 (0.0-1.5) | 0.5 (0.0-1.2) | 0.72 | 0.5 (0.0-1.5) | 0.34 |
| Fatigue (0-100) | 27 (5 - 89) | 28 (3 - 81) | 0.55 | 25 (6 - 74) | 0.70 |
| Muscle pain (0-100) | 30 (1 - 60) | 25 (2 - 69) | 0.92 | 23 (2 - 61) | 0.88 |
| Fear of falling (0-100) | 14 (0 -76) | 21 (2 - 71) | 0.75 | 33 (10-95) | 0.13 |
| SF-36 (0-100) | |||||
| Vitality | 45 (15 - 80) | 55 (35 - 70) | 0.26 | 50 (25 - 70) | 0.59 |
| Pain | 51 (0 - 84) | 62 (41 - 84) | 0.05 | 42 (22 - 100) | 0.17 |
| General health | 52 (35 - 82) | 50 (32 - 87) | 0.96 | 47 (35 - 97) | 0.92 |
| Mental health | 80 (40 - 92) | 76 (36 - 92) | 0.68 | 76 (56 - 92) | 0.59 |
| Physical functioning | 75 (25 - 95) | 70 (30 - 95) | 0.72 | 75 (25 - 95) | 0.91 |
| Social functioning | 75 (12 - 100) | 75 (25 - 100) | 0.03 | 62 (12 - 100) | 0.22 |
| Role emotional | 100 (0 - 100) | 100 (33 - 100) | 0.23 | 67 (0 - 100) | 0.86 |
| Role physical | 50 (0 - 100) | 75 (0 - 100) | 0.19 | 25 (0 - 100) | 0.91 |
| Self-efficacy (10-100) | |||||
| Pain | NA | 70 (18 - 100) | NA | 62 (18 - 86) | 0.45* |
| Function | 89 (54 - 100) | 88 (28 - 99) | 0.40 | 90 (61 - 100) | 0.22 |
| Symptoms | 75 (35 - 90) | 75 (42 - 100) | 0.45 | 78 (57-97) | 0.13 |
Values are median (range).
*T1 versus T2
NA = not assessed
HAQ = Health Assessment Questionnaire
SF-36 = Short Form Health Survey 36